AzTrials
AzTrials

Individual DifferenceNCT03429725

Increasing Individualism and Collectivism

A study testing Online prime (statements writing), Online prime (circling) and Online prime (Sumarian Warrior) in people with Individual Difference, run by Yale-NUS College at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An online survey is conducted on MTurk populations from India and USA. Participants were assigned either a condition with primes of individualism or one with primes of collectivism, before responding to a scale on culture and indicating details of their demographics. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Individual Difference
What is being tested?
Online prime (statements writing), Online prime (circling) and Online prime (Sumarian Warrior)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
495 participants
Where
1 siteSingapore
Study dates
17 Sep 2017to 23 Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • above age 21

Who cannot join

  • below age 21
  • not able to make decisions for self

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Yale-NUS College

    Singapore, 138527

Other trials in Singapore

About this study

Official title: Increasing Individualism or Collectivism on Amazon Mechanical Turk Participants

An online survey is conducted on MTurk populations from India and USA. Participants were assigned either a condition with primes of individualism or one with primes of collectivism, before responding to a scale on culture and indicating details of their demographics.

Being tested
Online prime (statements writing), Online prime (circling), Online prime (Sumarian Warrior), Online prime (all)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online prime (statements writing)Other

    Participants to write statements describing themselves or their similarities to their community.

  • Online prime (circling)Other

    Participants to circle either pronouns denoting themselves or pronouns denoting others.

  • Online prime (Sumarian Warrior)Other

    Participants read a passage which described the factors that led to his success in a war.

  • Online prime (all)Other

    Participants wrote statements, circled pronouns, as well as read the Sumarian Warrior passage.

Study groups in NCT03429725
Study groupRoleWhat they receive
IndividualismExperimentalParticipant will be randomly allocated to either the individualism condition or the collectivism condition. For individualism condition, participant is tasked to write statements relating to his/her differences from the his/her immediate community, circle pronouns that relate to the self, and read passages related to individualism.
Receives: Other: Online prime (statements writing); Other: Online prime (circling); Other: Online prime (Sumarian Warrior); Other: Online prime (all)
CollectivismExperimentalParticipant will be randomly allocated to either the individualism condition or the collectivism condition. For collectivism condition, participant is tasked to write statements relating to his/her similarities to the his/her immediate community, circle collective pronouns, and read passages related to collectivism.
Receives: Other: Online prime (statements writing); Other: Online prime (circling); Other: Online prime (Sumarian Warrior); Other: Online prime (all)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Higher collectivism or individualism level

    Individualism and collectivism levels will be measured by Triandis \& Gelfand (1998)'s "Culture Orientation Scale". This is a 16-item scale designed to measure: 1) Vertical Collectivism (VC) - seeing the self as a part of a collective and accepting hierarchy and inequality within that collective; 2) Vertical Individualism (VI) - seeing the self as fully autonomous, but recognizing and accepting the existence of inequality; 3) Horizontal Collectivism (HC) - seeing the self as part of a collective but viewing all the members of that collective as equal counterparts; and 4) Horizontal Individualism (HI) - seeing the self as fully autonomous, and believing in equality amongst individuals.

    All items are answered on a 5-point scale, ranging from 1= never or definitely no and 5 = always or definitely yes. Each dimension's items are summed up separately to create a VC, VI, HC, and HI score to reflect the level of collectivism and individualism in the sampled group.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2018
  2. Study start17 Sep 2017
  3. Primary completion23 Oct 2017
  4. Study completion23 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
495 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03429725
Sponsor's protocol ID
HSS-1502-P02-03
Status last verified
Feb 2018
First submitted
24 Nov 2017
Last updated
13 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Online prime (statements writing), Online prime (circling) and Online prime (Sumarian Warrior) in people with Individual Difference, run by Yale-NUS College at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Higher collectivism or individualism level (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in